Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Gliosarcoma 20Glioblastoma 20Central Nervous System Neoplasms 17Sarcoma 14Astrocytoma 6Glioma 5Osteosarcoma 4Liposarcoma 4Hemangiosarcoma 4Hemangiopericytoma, Malignant 4Fibrosarcoma 4Brain Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 3Sarcoma, Synovial 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Pheochromocytoma 1Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 17pembrolizumab 12Doxorubicin 10fludarabine 7Irinotecan 7Blood Specimen Collection 7Temozolomide 6Gemcitabine 6Etoposide 6Radiotherapy 5Ifosfamide 5Carboplatin 5Albumin-Bound Paclitaxel 5tecogalan 4cemiplimab 4Vincristine 4Trabectedin 4Paclitaxel 4Nivolumab 4Filgrastim 4Drug Therapy 4Dexamethasone 4Bevacizumab 4pazopanib 3olaparib 3nilotinib 3dostarlimab 3aflibercept 3Therapeutics 3Taxes 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Chemotherapy, Adjuvant × Sarcoma × Clear all
NCT00107003 2018-07-05

GW572016 to Treat Recurrent Malignant Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡